Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	141.21	174.96	127.11	218.04	293.48	507.14
Short-Term Investments	757.75	657.37	907.41	1,118	571.93	962.55
Cash & Short-Term Investments	898.95	832.33	1,035	1,336	865.41	1,470
Cash Growth	0.33%	-19.54%	-22.58%	54.40%	-41.12%	253.84%
Accounts Receivable	-	2.17	3.42	9.28	-	-
Other Receivables	1.4	-	-	-	1.23	5.67
Receivables	1.4	2.17	3.42	9.28	1.23	5.67
Prepaid Expenses	34.35	29.93	26.21	26.82	30.6	20.28
Total Current Assets	934.71	864.44	1,064	1,372	897.23	1,496
Property, Plant & Equipment	130.1	125.63	71.64	74.52	69.61	73.46
Long-Term Investments	78.46	374.37	-	-	425.45	32.7
Other Long-Term Assets	22.97	9.74	18.14	13.4	11.87	2.46
Total Assets	1,166	1,374	1,154	1,460	1,404	1,604
Accounts Payable	10.84	11.14	9.48	2.79	4.78	1.07
Accrued Expenses	50.07	64.91	61.24	59.37	47.71	42.46
Current Portion of Leases	10.29	12.03	7.26	7.32	5.45	4.69
Current Unearned Revenue	-	-	-	290.05	320.3	23.48
Other Current Liabilities	19.86	14.13	-	4.39	-	-
Total Current Liabilities	91.06	102.21	77.98	363.92	378.25	71.7
Long-Term Leases	37.69	42.29	44.98	53.03	58.55	64.18
Long-Term Unearned Revenue	-	-	-	0.48	4.69	317.17
Other Long-Term Liabilities	10.44	-	-	0.38	0.38	0.7
Total Liabilities	139.19	144.5	122.96	417.81	441.87	453.75
Common Stock	1.78	1.77	1.71	1.69	1.55	1.53
Additional Paid-In Capital	2,820	2,765	2,145	2,019	1,608	1,504
Retained Earnings	-1,796	-1,539	-1,116	-970.99	-645	-354.42
Comprehensive Income & Other	0.94	2.02	0.64	-6.89	-2.5	-0.25
Total Common Equity	1,027	1,230	1,031	1,042	962.29	1,151
Shareholders' Equity	1,027	1,230	1,031	1,042	962.29	1,151
Total Liabilities & Equity	1,166	1,374	1,154	1,460	1,404	1,604
Total Debt	47.97	54.32	52.24	60.35	64.01	68.87
Net Cash (Debt)	929.44	1,137	982.27	1,276	1,227	1,434
Net Cash Growth	-28.41%	15.79%	-23.01%	4.00%	-14.42%	274.57%
Net Cash Per Share	5.45	6.92	7.15	10.16	10.10	12.72
Filing Date Shares Outstanding	146.21	145.22	139.16	136.68	122.83	120.98
Total Common Shares Outstanding	145.69	144.22	138.39	135.97	122.28	120.53
Working Capital	843.65	762.23	986.16	1,008	518.99	1,424
Book Value Per Share	7.05	8.53	7.45	7.67	7.87	9.55
Tangible Book Value	1,027	1,230	1,031	1,042	962.29	1,151
Tangible Book Value Per Share	7.05	8.53	7.45	7.67	7.87	9.55
Machinery	-	60.37	50.35	37.6	32.97	26.91
Leasehold Improvements	-	46.91	41.24	43.7	35.24	34.74

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q